Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial
Yan‐Ping Mao(Sun Yat-sen University), Jun Ma(Shanghai Jiao Tong University), Yu‐Pei Chen(Sun Yat-sen University), Li Lin(Sun Yat-sen University), Tian-Sheng Gao(Wuzhou Red Cross Hospital), Yongjie Li(University of Macau), Guan‐Qun Zhou(Sun Yat-sen University), Yuan Zhang(Sun Yat-sen University), Xiaoyu Liang(Sun Yat-sen University), Shunxin Wang(Shandong University), Ying Sun(Qilu Hospital of Shandong University), Ling‐Long Tang(Sun Yat-sen University), Cheng Xu(Pennsylvania State University), Xu Liu(Sun Yat-sen University), Lei Chen(Cincinnati Children's Hospital Medical Center), Ning Zhang(First People's Hospital of Foshan), Lizhi Liu(Sun Yat-sen University), Rui Guo(Sun Yat-sen University), Jia‐Wei Lv(Zhejiang Chinese Medical University), Shaoqiang Liang(First People's Hospital of Foshan), Fang‐Yun Xie(Sun Yat-sen University), Wen‐Fei Li(Sun Yat-sen University), Jibin Li(Chongqing Public Health Medical Center)
Cited by 42
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
|Cancer Research|2019|423
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247